Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.

Human factor H interacts selectively with Neisseria gonorrhoeae and results in species-specific complement evasion.

Ngampasutadol J, Ram S, Gulati S, Agarwal S, Li C, Visintin A, Monks B, Madico G, Rice PA.

J Immunol. 2008 Mar 1;180(5):3426-35.

2.

Species-specificity of Neisseria gonorrhoeae infection: do human complement regulators contribute?

Ngampasutadol J, Tran C, Gulati S, Blom AM, Jerse EA, Ram S, Rice PA.

Vaccine. 2008 Dec 30;26 Suppl 8:I62-6. Review.

PMID:
19388167
3.

Human C4b-binding protein selectively interacts with Neisseria gonorrhoeae and results in species-specific infection.

Ngampasutadol J, Ram S, Blom AM, Jarva H, Jerse AE, Lien E, Goguen J, Gulati S, Rice PA.

Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17142-7. Epub 2005 Nov 7.

4.

C4bp binding to porin mediates stable serum resistance of Neisseria gonorrhoeae.

Ram S, Cullinane M, Blom AM, Gulati S, McQuillen DP, Boden R, Monks BG, O'Connell C, Elkins C, Pangburn MK, Dahlb├Ąck B, Rice PA.

Int Immunopharmacol. 2001 Mar;1(3):423-32. Review.

PMID:
11367527
5.

Molecular characterization of the interaction between porins of Neisseria gonorrhoeae and C4b-binding protein.

Jarva H, Ngampasutadol J, Ram S, Rice PA, Villoutreix BO, Blom AM.

J Immunol. 2007 Jul 1;179(1):540-7.

6.

Molecular characterization of the interaction between sialylated Neisseria gonorrhoeae and factor H.

Shaughnessy J, Ram S, Bhattacharjee A, Pedrosa J, Tran C, Horvath G, Monks B, Visintin A, Jokiranta TS, Rice PA.

J Biol Chem. 2011 Jun 24;286(25):22235-42. doi: 10.1074/jbc.M111.225516. Epub 2011 Apr 29.

7.

Factor H binding and function in sialylated pathogenic neisseriae is influenced by gonococcal, but not meningococcal, porin.

Madico G, Ngampasutadol J, Gulati S, Vogel U, Rice PA, Ram S.

J Immunol. 2007 Apr 1;178(7):4489-97.

8.

The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis.

Ram S, Mackinnon FG, Gulati S, McQuillen DP, Vogel U, Frosch M, Elkins C, Guttormsen HK, Wetzler LM, Oppermann M, Pangburn MK, Rice PA.

Mol Immunol. 1999 Sep-Oct;36(13-14):915-28. Review.

PMID:
10698346
9.
10.

Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae.

Ram S, Cullinane M, Blom AM, Gulati S, McQuillen DP, Monks BG, O'Connell C, Boden R, Elkins C, Pangburn MK, Dahlb├Ąck B, Rice PA.

J Exp Med. 2001 Feb 5;193(3):281-95.

12.
13.

Functional significance of factor H binding to Neisseria meningitidis.

Schneider MC, Exley RM, Chan H, Feavers I, Kang YH, Sim RB, Tang CM.

J Immunol. 2006 Jun 15;176(12):7566-75.

14.

Phosphoethanolamine residues on the lipid A moiety of Neisseria gonorrhoeae lipooligosaccharide modulate binding of complement inhibitors and resistance to complement killing.

Lewis LA, Shafer WM, Dutta Ray T, Ram S, Rice PA.

Infect Immun. 2013 Jan;81(1):33-42. doi: 10.1128/IAI.00751-12. Epub 2012 Oct 15.

15.

Complement processing and immunoglobulin binding to Neisseria gonorrhoeae determined in vitro simulates in vivo effects.

McQuillen DP, Gulati S, Ram S, Turner AK, Jani DB, Heeren TC, Rice PA.

J Infect Dis. 1999 Jan;179(1):124-35.

PMID:
9841831
16.

Binding of the complement inhibitor C4bp to serogroup B Neisseria meningitidis.

Jarva H, Ram S, Vogel U, Blom AM, Meri S.

J Immunol. 2005 May 15;174(10):6299-307.

17.

A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae.

Ram S, Sharma AK, Simpson SD, Gulati S, McQuillen DP, Pangburn MK, Rice PA.

J Exp Med. 1998 Mar 2;187(5):743-52.

18.
19.

A Novel Factor H-Fc Chimeric Immunotherapeutic Molecule against Neisseria gonorrhoeae.

Shaughnessy J, Gulati S, Agarwal S, Unemo M, Ohnishi M, Su XH, Monks BG, Visintin A, Madico G, Lewis LA, Golenbock DT, Reed GW, Rice PA, Ram S.

J Immunol. 2016 Feb 15;196(4):1732-40. doi: 10.4049/jimmunol.1500292. Epub 2016 Jan 15.

20.

Factor H and neisserial pathogenesis.

Welsch JA, Ram S.

Vaccine. 2008 Dec 30;26 Suppl 8:I40-5. Review.

Supplemental Content

Support Center